Patient Enrollment Complete in Thumb OA Study of Cartiva SCI

Cartiva completed enrollment and treatment of all 50 patients in a multi-center study evaluating the Synthetic Cartilage Implant (SCI) for first carpometacarpal joint osteoarthritis (OA) at the base of the thumb. The study was conducted at nine sites in Canada and the U.K.

In 3Q16, Cartiva received Premarket Approval from FDA for use of SCI to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us